Mutations in the RAS/MAPK pathway drive replication repair deficient hypermutated tumors and confer sensitivity to MEK inhibition.
暂无分享,去创建一个
Trevor J Pugh | T. Pugh | C. Hawkins | J. Maris | B. Campbell | Matthew Zatzman | A. Shlien | A. Morrissy | Michael D. Taylor | D. Malkin | P. Ohashi | U. Tabori | E. Bouffet | M. Zapotocky | S. Kalimuthu | M. Aronson | G. Mason | Robert Siddaway | M. Komosa | D. Morgenstern | C. Durno | Alexandra N Riemenschneider | David Samuel | N. Nunes | L. Nobre | M. Edwards | S. Stone | Sumedha Sudhaman | Melissa A. Galati | Lazar Joksimovic | M. Zápotocký | R. Siddaway | M. Zatzman | M. Galati | S. Sudhaman